Carbamazepine overdose after exposure to simethicone: a case report.

J Med Case Rep

Marmara University, School of Medicine, Department of Emergency Medicine, Istanbul, Turkey.

Published: July 2008

Introduction: Carbamazepine is an anticonvulsant drug and is also used as a treatment for patients with manic-depressive illness, post-herpetic neuralgia or phantom limb pain. The drug itself has many drug interactions. Simethicone is an antifoaming agent and is reported to be an inert material with no known drug interaction with carbamazepine.

Case Presentation: We present a case of a patient who was routinely using carbamazepine 400 mg three times per day and levetiracetam 500 mg twice daily, and experienced carbamazepine overdose after exposure to simethicone. After cessation of simethicone therapy normal drug levels of carbamazepine were obtained again with the standard dose of the drug. The mechanism of interaction is unknown but the risk of overdose should be considered when prescribing simethicone to a patient who is using carbamazepine.

Conclusion: Simethicone and carbamazepine, when taken together, may be a cause of carbamazepine toxicity. The risk of carbamazepine overdose should be considered when prescribing simethicone to a patient who is using carbamazepine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495000PMC
http://dx.doi.org/10.1186/1752-1947-2-242DOI Listing

Publication Analysis

Top Keywords

carbamazepine overdose
12
carbamazepine
9
overdose exposure
8
exposure simethicone
8
overdose considered
8
considered prescribing
8
prescribing simethicone
8
simethicone patient
8
simethicone
7
drug
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!